E/M Coding Alert - 2002 Issue 5
Pathology Report,Table Essential to Coding Cancer Diagnoses
Subscribe or sign in to view the full article.
Article Overview
This article discusses how pathology reports affect cancer-related diagnosis coding, with emphasis on the ICD-9 table of neoplasms and the broad categories used to classify neoplastic conditions. It is aimed at coders, billers, and clinical staff who need to understand when pathology confirmation matters and why accurate diagnosis selection can affect reimbursement and patient record implications. The article also touches on payer considerations, documentation timing, and related billing issues for masses and lesions.
Why This Topic Matters
Correct neoplasm coding can affect claim accuracy, payment outcomes, and how a patient’s record is documented. Understanding the role of pathology helps coders distinguish among general neoplasm categories and reduces the risk of using unsupported diagnoses.
Article Sections
-
Introduction
Introduces the importance of pathology confirmation in cancer diagnosis coding and the challenges of using the ICD-9 neoplasm table.
-
Categories of Malignant Neoplasms
Summarizes the main malignant neoplasm categories described in the article and the role of pathology in identifying them.
-
Other Categories of Neoplasms
Reviews the nonmalignant neoplasm categories and general billing considerations associated with them.
What You Will Learn
- How pathology reports influence neoplasm diagnosis coding
- How the ICD-9 neoplasm table is organized at a broad level
- The general categories used for malignant and nonmalignant neoplasms
- Why documentation timing can affect reimbursement and claim handling
- General payer and patient-account implications related to uncertain diagnosis coding
Who Should Read This
- Medical coders
- Medical billers
- Physician office staff
- Surgery coding staff
- Reimbursement specialists
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com